3649 results for «414»
3649 results
Advances in STEMI and Stable CAD
22 Sep 2023 – From AICT-AsiaPCR 2023
Explore cutting-edge insights into STEMI and Stable CAD through these presentations: delve into the intricate details of characterizing culprit coronary lesions in STEMI patients using OCT, uncover the short- and long-term outcomes for Asian STEMI patients following primary PCI and gain a comprehensive understanding of the...
How to manage complications in CTO PCI
22 Sep 2023 – From AICT-AsiaPCR 2023
Explore complex CTO PCI scenarios and gain insights into complications and their solutions in this session. Topics include CTO vessel rupture after a covered stent bailout, epicardial channel perforation management, dissection from collateral tip injection, and more!
Spontaneous coronary artery disease, INOCA, MINOCA in women
21 Sep 2023 – From AICT-AsiaPCR 2023
Consult this session to better understand the causes of myocardial infarction without obstructive disease (MINOCA), to revisit ischemia with no obstructive coronary atherosclerosis (INOCA), and to broaden your understanding of spontaneous coronary artery dissection (SCAD) beyond its association with pregnancy.
Next-gen complex interventional techniques and solutions
21 Sep 2023 – From AICT-AsiaPCR 2023
Join us in this session where experts delve into advanced techniques for complex interventions: discover tips for PCI without metallic stents, explore novel tools for bifurcation and complex lesions, and learn from clinical experiences in managing long diffused lesions.
Innvolution Healthcare reports one-year findings from the ALCHEMY study evaluating Eternia in 1000 patients at EuroPCR 2026
27 May 2026
Four-Year Outcomes from the EVOLUT Low Risk Trial
26 Oct 2023
Dejan Milasinovic provides his take on the EVOLUT Low Risk trial, presented by Michael I. Reardon at TCT Congress 2023. 4-year results reveal a continuing trend towards lower combined rates of all-cause mortality and disabling stroke with TAVI compared with surgical aortic valve replacement (SAVR)
Author
5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)
01 Apr 2025
Yohei Ohno provides his takeaways from the results of the Evolut Low Risk trial which was presented by Michael J. Reardon during the ACC.25 in Chicago.
Author
Cardiac biomarkers in patients with asymptomatic severe aortic stenosis: primary biomarker analysis from the EARLY TAVR Trial
01 Apr 2025
Elad Asher provides his take on the primary biomarker analysis from the EARLY TAVR Trial presented by Brian R. Lindman at ACC.25 in Chicago.
Author
Transcatheter vs surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut Low Risk trial
05 Mar 2023
Luigi Biasco provides his take on the clinical trial presented by John K. Forrest from Yale University School of Medicine, New Haven, Connecticut, USA during the 2023 ACC/WCC annual congress held in New Orleans, Louisiana.
Author
